Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neuroone Medical Technologies (NMTC) Shares Outstanding (Diluted Average) (2021 - 2025)

Historic Shares Outstanding (Diluted Average) for Neuroone Medical Technologies (NMTC) over the last 6 years, with Q4 2025 value amounting to $50.3 million.

  • Neuroone Medical Technologies' Shares Outstanding (Diluted Average) rose 6298.73% to $50.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $50.3 million, marking a year-over-year increase of 6298.73%. This contributed to the annual value of $40.2 million for FY2025, which is 5003.47% up from last year.
  • Latest data reveals that Neuroone Medical Technologies reported Shares Outstanding (Diluted Average) of $50.3 million as of Q4 2025, which was up 6298.73% from $40.2 million recorded in Q3 2025.
  • In the past 5 years, Neuroone Medical Technologies' Shares Outstanding (Diluted Average) registered a high of $50.3 million during Q4 2025, and its lowest value of $10.7 million during Q3 2021.
  • Its 5-year average for Shares Outstanding (Diluted Average) is $23.6 million, with a median of $17.8 million in 2023.
  • Per our database at Business Quant, Neuroone Medical Technologies' Shares Outstanding (Diluted Average) skyrocketed by 138.93% in 2023 and then soared by 7769.75% in 2025.
  • Neuroone Medical Technologies' Shares Outstanding (Diluted Average) (Quarter) stood at $15.4 million in 2021, then grew by 5.34% to $16.2 million in 2022, then surged by 47.84% to $24.0 million in 2023, then rose by 28.69% to $30.9 million in 2024, then soared by 62.99% to $50.3 million in 2025.
  • Its Shares Outstanding (Diluted Average) stands at $50.3 million for Q4 2025, versus $40.2 million for Q3 2025 and $48.6 million for Q2 2025.